Creation of a long-acting nanoformulated dolutegravir

Código QR

Creation of a long-acting nanoformulated dolutegravir

Current ART for treatment of HIV-1 infection requires a strict daily regimen adherence. Herein, the authors report the manufacture and characterization of a nanoformulated dolutegravir prodrug with improved cell and tissue penetration, a remarkable apparent half-life and the potential for bimonthly...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Brady Sillman, Aditya N. Bade, Prasanta K. Dash, Biju Bhargavan, Ted Kocher, Saumi Mathews, Hang Su, Georgette D. Kanmogne, Larisa Y. Poluektova, Santhi Gorantla, JoEllyn McMillan, Nagsen Gautam, Yazen Alnouti, Benson Edagwa, Howard E. Gendelman
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2018
Materias:	Science Q
Acceso en línea:	https://doaj.org/article/9fe938444e464eaea1e85845549ff241
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice
por: Biju Bhargavan, et al.
Publicado: (2021)

Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profiles
por: Denise A. Cobb, et al.
Publicado: (2021)

Synthesis and characterization of a long-acting emtricitabine prodrug nanoformulation
por: Ibrahim IM, et al.
Publicado: (2019)

Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells
por: Kanmogne GD, et al.
Publicado: (2012)

Lipophilic nanocrystal prodrug-release defines the extended pharmacokinetic profiles of a year-long cabotegravir
por: Nagsen Gautam, et al.
Publicado: (2021)

Comparative manufacture and cell-based delivery of antiretroviral nanoformulations
por: Balkundi S, et al.
Publicado: (2011)

Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice
por: Prasanta K. Dash, et al.
Publicado: (2019)

Dolutegravir/rilpivirine for the treatment of HIV-1 infection
por: Dowers E, et al.
Publicado: (2018)

Dolutegravir And Lamivudine Combination For The Treatment Of HIV-1 Infection
por: Zamora FJ, et al.
Publicado: (2019)

Potential benefit of dolutegravir once daily: efficacy and safety
por: Fantauzzi A, et al.
Publicado: (2013)

EXPERIENCE WITH DOLUTEGRAVIR IN HIV PATIENTS AT A PUBLIC SECTOR HOSPITAL IN KARACHI, PAKISTAN
por: Farzana Batool, et al.
Publicado: (2021)

In vitro analysis of PARP inhibitor nanoformulations
por: Baldwin P, et al.
Publicado: (2018)

Nanoformulations of natural products for management of metabolic syndrome
por: Taghipour YD, et al.
Publicado: (2019)

The Effect of Moderate- and High-Fat Meals on the Bioavailability of Dolutegravir/Rilpivirine Fixed-Dose Combination Tablet
por: Mehta R, et al.
Publicado: (2020)

The R263K Dolutegravir Resistance-Associated Substitution Progressively Decreases HIV-1 Integration
por: Thibault Mesplède, et al.
Publicado: (2017)

Patient experiences of switching from Efavirenz- to Dolutegravir-based antiretroviral therapy: a qualitative study in Uganda
por: Adelline Twimukye, et al.
Publicado: (2021)

Pharmacology and Pharmacokinetics of Vitamin E: Nanoformulations to Enhance Bioavailability
por: Mohd Zaffarin AS, et al.
Publicado: (2020)

Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes
por: Yallapu MM, et al.
Publicado: (2011)

Magnetic resonance imaging of folic acid-coated magnetite nanoparticles reflects tissue biodistribution of long-acting antiretroviral therapy
por: Li T, et al.
Publicado: (2015)

Protocol for active safety monitoring of a cohort of patients using a dolutegravir-based antiretroviral regimen in Mozambique
por: Tamara Hafner, et al.
Publicado: (2021)

Heparin and Arginine Based Plasmin Nanoformulation for Ischemic Stroke Therapy
por: Ramsha Aamir, et al.
Publicado: (2021)

Advanced drug delivery to the lymphatic system: lipid-based nanoformulations
por: Ali Khan A, et al.
Publicado: (2013)

Polyphenol nanoformulations for cancer therapy: experimental evidence and clinical perspective
por: Davatgaran-Taghipour Y, et al.
Publicado: (2017)

Recent ultrasound advancements for the manipulation of nanobiomaterials and nanoformulations for drug delivery
por: Sze Shin Low, et al.
Publicado: (2021)

Nanoformulated cell-penetrating survivin mutant and its dual actions
por: Sriramoju B, et al.
Publicado: (2014)

How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance against the Integrase Inhibitor Dolutegravir
por: Atze T. Das, et al.
Publicado: (2018)

Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction
por: Qi Q, et al.
Publicado: (2017)

Erratum for Mesplède et al., “The R263K Dolutegravir Resistance-Associated Substitution Progressively Decreases HIV-1 Integration”
por: Thibault Mesplède, et al.
Publicado: (2018)

An effective strategy for development of docetaxel encapsulated gold nanoformulations for treatment of prostate cancer
por: S. Thambiraj, et al.
Publicado: (2021)

Therapeutic Potential of Thymoquinone and Its Nanoformulations in Pulmonary Injury: A Comprehensive Review
por: Al-Gabri NA, et al.
Publicado: (2021)

A dual-targeted multifunctional nanoformulation for potential prevention and therapy of Alzheimer's disease
por: Dongju Zhao, et al.
Publicado: (2021)

Effect of the nanoformulation of siRNA-lipid assemblies on their cellular uptake and immune stimulation
por: Kubota K, et al.
Publicado: (2017)

Improved Antibacterial Activity of Water-Soluble Nanoformulated Kaempferol and Combretastatin Polyphenolic Compounds
por: Y. Santhosh Kumar, et al.
Publicado: (2021)

Reply to Das and Berkhout, “How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance against the Integrase Inhibitor Dolutegravir”
por: Isabelle Malet, et al.
Publicado: (2018)

Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response
por: Yin P, et al.
Publicado: (2020)

Development of TIMP1 magnetic nanoformulation for regulation of synaptic plasticity in HIV-1 infection
por: Atluri VSR, et al.
Publicado: (2016)

Consequences Of Long-Term Bacteria’s Exposure To Silver Nanoformulations With Different PhysicoChemical Properties
por: Kędziora A, et al.
Publicado: (2020)

Anti‐inflammatory ethosomal nanoformulation in combination with iontophoresis in chronic wound healing: An ex vivo study
por: Reza Mombeiny, et al.
Publicado: (2021)

Exploiting the Anti-Inflammatory Potential of White <i>Capsicum</i> Extract by the Nanoformulation in Phospholipid Vesicles
por: Ilaria Pappalardo, et al.
Publicado: (2021)

Doxorubicin-loaded quaternary ammonium palmitoyl glycol chitosan polymeric nanoformulation: uptake by cells and organs
por: Kanwal U, et al.
Publicado: (2018)